Alexander Mörseburg

Alexander Mörseburg

Auto-generated profile, based on publicly available information

Alexander Mörseburg

MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2016 in European Journal of Human Genetics
Verified
Journal Article
Closed access
AMAlexander Mörseburg
Alexander Mörseburg
LPLuca Pagani
Luca Pagani
FRFrançois Xavier Ricaut
François Xavier Ricaut
BYBryndis Yngvadottir
Bryndis Yngvadottir
EHEadaoin Harney
Eadaoin Harney
TKToomas Kivisild
Toomas Kivisild

28 March 2025 in Science
Verified
Journal Article
Open access
Natalie WallisNatalie Wallis
Natalie Wallis
AMAlyce McClellan
Alyce McClellan
AMAlexander Mörseburg
Alexander Mörseburg
KKKatherine A. Kentistou
Katherine A. Kentistou
AJAqfan Jamaluddin
Aqfan Jamaluddin
EREleanor Raffan
Eleanor Raffan
Obesity is a heritable disease, but its genetic basis is incompletely understood. Canine population history facilitates trait mapping. We performed a canine genome-wide association study for body condition score—a measure of obesity—in 241 Labrador retrievers. Using a cross-species approach, we showed that canine obesity genes are also associated with rare and common forms of obesity in humans. The lead canine association was within the gene DENN domain containing 1B ( DENND1B ). Each copy of the alternate allele was associated with ~7% greater body fat. We demonstrate a role for this gene in regulating signaling and trafficking of melanocortin 4 receptor, a critical controller of energy homeostasis. Thus, canine genetics identified obesity genes and mechanisms relevant to both dogs and humans.

5 May 2022 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
AMAlexander Mörseburg
Alexander Mörseburg
LPLuca Pagani
Luca Pagani
BMBoris Malyarchuk
Boris Malyarchuk
MDMiroslava Derenko
Miroslava Derenko
TKToomas Kivisild
Toomas Kivisild

26 April 2025 in npj Aging
Verified
Journal Article
Open access
PDF file
AMAlexander Mörseburg
Alexander Mörseburg
YZYajie Zhao
Yajie Zhao
KKKatherine A. Kentistou
Katherine A. Kentistou
JPJohn R. B. Perry
John R. B. Perry
KOKen K. Ong
Ken K. Ong
FDFelix R. Day
Felix R. Day
Changes in the proteome and its dysregulation have long been known to be a hallmark of aging. We derived a proteomic aging trait using data on 1459 plasma proteins from 44,435 UK Biobank individuals measured using an antibody-based assay. This metric is strongly associated with four age-related disease outcomes, even after adjusting for chronological age. Survival analysis showed that one-year older proteomic age, relative to chronological age, increases all-cause mortality hazard by 13 percent. We performed a genome-wide association analysis of proteomic age acceleration (proteomic aging trait minus chronological age) to identify its biological determinants. Proteomic age acceleration showed modest genetic correlations with four epigenetic clocks (R g = 0.17 to 0.19) and telomere length (R g = −0.2). Once we removed associations that were explained by a single pQTL, we were left with three signals mapping to BRCA1, POLR2A and TET2 with apparent widespread effects on plasma proteomic aging. Genetic variation at these three loci has been shown to affect other omics-related aging measures. Mendelian randomisation analyses showed causal effects of higher BMI and type 2 diabetes on faster proteomic age acceleration. This supports the idea that obesity and other features of metabolic syndrome have an adverse effect on the processes of human aging.